Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $12.27 Analyst target: $16.82 Upside: 37.08%
AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.